Image Analysis
NEW ORLEANS – An artificial intelligence (AI) model trained using sequential health information derived from electronic health records identified a subset of individuals with a 25-fold risk of developing pancreatic cancer within three to 36...
aetherAI Machine Learning Approach for Classification of Primary Intestinal T-Cell Lymphomas Published in Cancers TAIPEI, TAIWAN, April 6, 2022 /EINPresswire.com/ -- aetherAI—Asia’s leading medical image AI solution provider focused on...
BOSTON — April 5, 2022 — PathAI, a global leader in AI-powered pathology, and GlaxoSmithKline (GSK), today announced a strategic multi-year partnership to accelerate scientific research and drug development programs in oncology and...
Join Deep Bio at AACR 2022! At this year’s AACR, Deep Bio will present both on-site and virtually! Visit us at booth #1461 to share your thoughts on the role of digital pathology and AI in cancer research. Also, don’t forget to see the...
PARIS, France and CAMBRIDGE, Mass. – Keen Eye, a leading AI company in digital pathology for clinical research and Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies,...
March 21, 2022: Today, Visiopharm launches Qualitopix™ for AI-driven standardization of tissue staining at USCAP 2022 is introducing its novel and unique Qualitopix™ solution to delegates at the United States and Canadian Academy of...
